To the full analysis
Mersen stock: growth
MRN.PAMersen reported $1.31B in revenue for fiscal 2025, down 4.6% on the prior year, up 7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.3%
per year from 2006 to 2025, per share 1.4%
Earnings (Annual rate)
−4.7%
per year from 2006 to 2025, per share −6.9%
Free cash flow (Annual rate)
4.7%
per year from 2006 to 2025, per share 2.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 7.0% | 4.5% | 3.3% |
| Revenue per share | 6.3% | 4.1% | 1.4% |
| Earnings | no data | 26.9% | −4.7% |
| Earnings per share | no data | 24.1% | −6.9% |
| Free cash flow | −12.4% | 10.1% | 4.7% |
| Free cash flow per share | −12.9% | 9.8% | 2.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $708.96M | $39.12M | $16.51M |
| 2007 | $768.69M | $18.06M | −$13.41M |
| 2008 | $733.45M | $33.02M | $3.21M |
| 2009 | $650.79M | $16.51M | $57.51M |
| 2010 | $821.32M | $44.1M | $67.59M |
| 2011 | $919.28M | $63.05M | $15.74M |
| 2012 | $898.34M | $7.2M | $65.16M |
| 2013 | $818.66M | −$32.36M | $56.4M |
| 2014 | $804.59M | $2.33M | $37.01M |
| 2015 | $850.58M | $1.44M | $15.07M |
| 2016 | $841.05M | $1.99M | $55.52M |
| 2017 | $896.67M | $41.66M | $32.47M |
| 2018 | $973.47M | $62.61M | $40M |
| 2019 | $1.05B | $63.49M | $64.05M |
| 2020 | $938.78M | −$13.3M | $76.57M |
| 2021 | $1.02B | $60.28M | $26.71M |
| 2022 | $1.24B | $75.02M | $9.09M |
| 2023 | $1.34B | $90.42M | −$8.86M |
| 2024 | $1.38B | $65.38M | −$25.04M |
| 2025 | $1.31B | $15.62M | $39.56M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Apr 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.